NuCana (NCNA) Assets Average (2017 - 2025)
NuCana (NCNA) reported Assets Average of $41.6 million for Q4 2025, up 87.83% on a YoY basis from $22.2 million in Q4 2024, and up 27.66% sequentially from $32.6 million in Q3 2025.
NuCana (NCNA) Assets Average (2017 - 2025) Analysis & Trends
NuCana (NCNA) has 9 years of Assets Average data on file, last reported at $41.6 million in Q4 2025.
- For the quarter ending Q4 2025, Assets Average rose 87.83% year-over-year to $41.6 million; the trailing twelve-month figure through Dec 2025 stood at $41.6 million (up 87.83% YoY), and the FY2025 full-year result was $29.1 million, up 8.87% from the prior year.
- Assets Average improved to $41.6 million in Q4 2025, from $32.6 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $140.7 million in Q1 2021 to a low of $16.8 million in Q1 2025.
- A 5-year average of $64.3 million and a median of $51.4 million in 2023 frame the typical range for Assets Average.
- Peak annual rise in Assets Average reached 87.83% in 2025, while the deepest fall reached 49.11% in 2025.
- Tracing NCNA's Assets Average over 5 years: stood at $114.1 million in 2021, then plunged by 34.6% to $74.6 million in 2022, then tumbled by 48.04% to $38.8 million in 2023, then sank by 42.82% to $22.2 million in 2024, then jumped by 87.83% to $41.6 million in 2025.
- Business Quant data shows NCNA's Assets Average at $41.6 million in Q4 2025, $32.6 million in Q3 2025, and $18.1 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 303.40 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | 65.01 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 40.89 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 8.37 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 26.06 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 40.71 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 795.91 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 2.30 Bn |
| 10 | NuCana | 14.60 Bn | 14.60 Bn | - | 41.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 41.64 Mn |
| Sep 30, 2025 | 32.62 Mn |
| Jun 30, 2025 | 18.12 Mn |
| Mar 31, 2025 | 16.79 Mn |
| Dec 31, 2024 | 22.17 Mn |
| Sep 30, 2024 | 25.36 Mn |
| Jun 30, 2024 | 28.40 Mn |
| Mar 31, 2024 | 32.99 Mn |
| Dec 31, 2023 | 38.77 Mn |
| Sep 30, 2023 | 47.33 Mn |
| Jun 30, 2023 | 55.44 Mn |
| Mar 31, 2023 | 63.79 Mn |
| Dec 31, 2022 | 74.62 Mn |
| Sep 30, 2022 | 82.41 Mn |
| Jun 30, 2022 | 89.87 Mn |
| Mar 31, 2022 | 100.14 Mn |
| Dec 31, 2021 | 114.11 Mn |
| Sep 30, 2021 | 126.41 Mn |
| Jun 30, 2021 | 134.07 Mn |
| Mar 31, 2021 | 140.71 Mn |